Enhancing Clinical Workflows and Optimizing Efficiencies – with Patricio La Rosa of Bayer
Clinical trials comprise the most significant portion of drug development costs. In some cases, drug R&D costs can approach as high as $2 billion per drug and are accompanied by protracted timelines of 10-15 years. Pharmaceutical companies are turning to AI to shorten discovery timelines while dramatically upholding rigorous standards. AI-driven approaches have demonstrated meaningful…
